ArticleBioinformatics (Oxford, England)2026
scLDM: a conditional diffusion framework for single-cell perturbation prediction.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
motivationAccurate prediction of single-cell responses to external stimuli is pivotal for deciphering gene regulatory mechanisms and accelerating data-driven drug discovery. However, effectively capturing the complex, non-linear mapping between intrinsic cell states and external stimuli remains an open problem.
resultsWe propose scLDM, a generative framework based on latent diffusion models for predicting single-cell perturbation responses. scLDM first compresses high-dimensional gene expression into a compact latent space via a variational autoencoder, followed by a conditional diffusion process to generate post-perturbation states, explicitly guided by pre-perturbation cellular state, cell type, and perturbation type. Systematic evaluations on six datasets across diverse biological settings, spanning pharmacological stimulation, viral infection, helminth infection, genetic perturbations, and multi-species immune response contexts, demonstrate that scLDM achieves superior predictive accuracy compared to state-of-the-art methods. Furthermore, the model exhibits strong interpretability, as the learned perturbation embeddings show high functional alignment with known biological mechanisms. Overall, scLDM provides a robust and biologically consistent strategy for in silico perturbation screening. AVAILABILITY: The code is available at https://github.com/samrogers1233/scLDM and archived on Zenodo at https://doi.org/10.5281/zenodo.22658164.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.